{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:31:14Z","timestamp":1778902274968,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T00:00:00Z","timestamp":1454025600000},"content-version":"am","delay-in-days":334,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development (USAID): the Contraceptive and Reproductive Health Technologies and Research Utilization Program","doi-asserted-by":"publisher","award":["GPO-A-00-05-00022-00"],"award-info":[{"award-number":["GPO-A-00-05-00022-00"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Preventive Technologies Agreement","award":["GHO-A-00-09-00016-00"],"award-info":[{"award-number":["GHO-A-00-09-00016-00"]}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.contraception.2014.10.008","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T13:33:02Z","timestamp":1413984782000},"page":"248-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Sino-implant (II)\u00ae continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya"],"prefix":"10.1016","volume":"91","author":[{"given":"Catherine S.","family":"Todd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Deese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hubacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus J.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Otunga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lut","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2014.10.008_bb0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.contraception.2009.10.013","article-title":"Sino-implant (II) \u2014 a levonorgestrel-releasing two-rod implant: systematic review of the randomized controlled trials","volume":"81","author":"Steiner","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.10.008_bb0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.contraception.2013.03.006","article-title":"Performance of Sino-implant (II) in routine service delivery in Madagascar","volume":"88","author":"Feldblum","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.10.008_bb0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.contraception.2013.11.002","article-title":"Effectiveness, safety and acceptability of Sino-implant (II) during the first year of use: results from Kenya and Pakistan","volume":"89","author":"Lendvay","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.10.008_bb0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0010-7824(01)00294-3","article-title":"Mechanisms that explain the contraceptive action of progestin implants for women","volume":"65","author":"Croxatto","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.10.008_bb0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0010-7824(97)00153-4","article-title":"First week drug concentrations in women with levonorgestrel rods or Norplant\u00ae capsule implants","volume":"56","author":"Sivin","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.10.008_bb0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0010-7824(01)00226-8","article-title":"Levonorgestrel concentrations during 7years of continuous use of Jadelle contraceptive implants","volume":"64","author":"Sivin","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.10.008_bb0035","doi-asserted-by":"crossref","first-page":"18448","DOI":"10.7448\/IAS.16.1.18448","article-title":"Effect of concurrent use of anti-retroviral therapy and levonorgestrel sub-dermal implant for contraception on CD4 counts: a prospective cohort study in Kenya","volume":"16","author":"Hubacher","year":"2013","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.contraception.2014.10.008_bb0040","doi-asserted-by":"crossref","first-page":"890160","DOI":"10.1155\/2012\/890160","article-title":"Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy","volume":"2012","author":"Robinson","year":"2012","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.contraception.2014.10.008_bb0045","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1097\/QAD.0000000000000290","article-title":"Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception","volume":"28","author":"Murnane","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.contraception.2014.10.008_bb0050","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Partners PrEP Study Team. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2014.10.008_bb0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure prophylaxis for HIV infection among African women","volume":"367","author":"Van Damme","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2014.10.008_bb0060","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/QAI.0000000000000158","article-title":"FEM-PrEP: adherence patterns and factors associated with adherence to a daily, oral study product for pre-exposure prophylaxis","volume":"66","author":"Corneli","year":"2014","journal-title":"In press, J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.contraception.2014.10.008_bb0065","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/00003495-199855060-00019","article-title":"Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability","volume":"55","author":"Coukell","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.contraception.2014.10.008_bb0070","first-page":"351","article-title":"Changes in serum estradiol, progesterone and levonorgestrel levels in women during five years after insertion of Sino-Implant","volume":"16","author":"Zheng","year":"1996","journal-title":"Reprod Contracept"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078241400732X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078241400732X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:11:05Z","timestamp":1757880665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001078241400732X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S001078241400732X"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2014.10.008","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sino-implant (II)\u00ae continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2014.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}